Probing Trypanosoma cruzi biology with DNA microarrays.
The application of genome-scale approaches to study Trypanosoma cruzi-host interactions at different stages of the infective process is becoming possible with sequencing and assembly of the T. cruzi genome nearing completion and sequence information available for both human and mouse genomes. Investigators have recently begun to exploit DNA microarray technology to analyze host transcriptional responses to T. cruzi infection and dissect developmental processes in the complex T. cruzi life-cycle. Collectively, information generated from these and future studies will provide valuable insights into the molecular requirements for establishment of T. cruzi infection in the host and highlight the molecular events coinciding with disease progression. While the field is in its infancy, the availability of genomic information and increased accessibility to relatively high-throughput technologies represents a significant advancement toward identification of novel drug targets and vaccine candidates for the treatment and prevention of Chagas' disease.
Burleigh
B A
BA
Department of Immunology and Infectious Diseases, Harvard School of Public Health, 665 Huntingzon Ave, Boston, MA 02115, USA. bburleig@hsph.harvard.edu
D000818:Animals; D014355:Chagas Disease / Q000469:parasitology*; D004195:Disease Models, Animal; D018503:Genome, Protozoan; D054884:Host-Pathogen Interactions; D006801:Humans; D020411:Oligonucleotide Array Sequence Analysis; D014158:Transcription, Genetic; D014349:Trypanosoma cruzi / Q000235:genetics*